Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.020
0.00 (0.00%)
At close: Oct 29, 2026, 4:00 PM EDT
1.020
0.00 (0.00%)
Pre-market: Oct 30, 2026, 7:15 AM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $43.46 million as of October 29, 2026. It is the 31,080th most valuable company in the world and the 4,703rd biggest in the United States. Its market cap has decreased by 20.76% in one year.
Market Cap
43.46M
Enterprise Value
24.73M
1-Year Change
-20.76%
Global Rank
Country Rank
#4,703 United States
Category
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $43.46M, a decrease of -30.48%. That is a compound annual growth rate of -5.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 43.46M | -52.61% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImageneBio | 45.63M |
| Actinium Pharmaceuticals | 44.65M |
| Kalaris Therapeutics | 44.28M |
| Apollomics | 42.95M |
| Serina Therapeutics | 42.42M |
| INmune Bio | 42.19M |
| GridAI Technologies | 41.32M |
| Adicet Bio | 41.01M |